Search Results 151-160 of 12277 for fibrosis quistica

1. Efficacy And Safety Of SAR156597 In The Treatment Of Idiopathic Pulmonary Fibrosis - Mayo Clinic

   ... Fibrosis (IPF). Secondary Objectives: To evaluate the efficacy of 2 dose levels of SAR156597 compared to placebo on IPF disease progression. To evaluate the ...

2. Interstitial lung disease: Genetic testing and antifibrotic selection (Part 2 of 3) - Mayo Clinic

   Mayo Clinic specialists are advancing ILD care through genetic testing for familial pulmonary fibrosis, inherited risk assessment and emerging antifibrotic ...

3. A Study To Evaluate PRM-151 In Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   ... fibrosis (IPF). Specific objectives and corresponding endpoints for the study are outlined below. Participation eligibility. Participant eligibility includes ...

4. Doctors and departments - Mayo Clinic

   Research. Mayo Clinic pulmonary scientists study pulmonary fibrosis and other lung diseases and do clinical trials. Mayo researchers study the causes, ...

5. A Study To Evaluate The Impact On NASH With Fibrosis Of Obeticholic Acid Treatment - Mayo Clinic

   The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver- ...

6. A Study to Evaluate the Prevalence of Mitochondrial DNA Mutations Associated with Toxicity to the Ear in the Cystic Fibrosis Population - Mayo Clinic

   A Study to Evaluate the Prevalence of Mitochondrial DNA Mutations Associated with Toxicity to the Ear in the Cystic Fibrosis Population.

7. Liver fibrosis - Doctors and departments - Mayo Clinic

   Mayo researchers were among the first to identify metabolic dysfunction-associated steatotic liver disease and primary sclerosing cholangitis, liver conditions ...

8. A Study To Evaluate PRM-151 In Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   ... fibrosis (IPF). Specific objectives and corresponding endpoints for the study are outlined below. Participation eligibility. Participant eligibility includes ...

9. A Study of OX40L As a Functional Biomarker for Liver Fibrosis - Mayo Clinic

   The primary purpose of this study is to investigate whether the abundance of OX40L expression is associated with the development of hepatic fibrosis.

10. A Study To Evaluate The Effectiveness Of A Dexamethasone Eluting Slim Modiolar Electrode In The Reduction Of Fibrosis In A Newly Implanted Adult Population With Bilateral, Post-Linguistic, Moderate To Profound Sensorineural Hearing Loss - Mayo Clinic

    A Study To Evaluate The Effectiveness Of A Dexamethasone Eluting Slim Modiolar Electrode In The Reduction Of Fibrosis In A Newly Implanted Adult Population ...